SUSQUEHANNA INTERNATIONAL GROUP, LLP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$431,280
-46.0%
299,500
-6.6%
0.00%
Q2 2023$798,720
-19.1%
320,771
-12.9%
0.00%
Q1 2023$986,972
-59.4%
368,273
-17.8%
0.00%
-100.0%
Q4 2022$2,433,140
-25.2%
448,092
+72.2%
0.00%0.0%
Q3 2022$3,251,000
+535.0%
260,262
+150.9%
0.00%
Q2 2022$512,000
-55.7%
103,728
-31.9%
0.00%
Q1 2022$1,157,000
-76.1%
152,295
-67.9%
0.00%
Q4 2021$4,846,000
+56.4%
474,672
+105.6%
0.00%
Q3 2021$3,098,000
-46.4%
230,846
-12.4%
0.00%
Q2 2021$5,779,000
-63.7%
263,393
-60.2%
0.00%
-100.0%
Q1 2021$15,934,000
+1.4%
662,244
-24.2%
0.00%
+50.0%
Q4 2020$15,716,000
+1528.6%
873,628
+946.7%
0.00%
Q3 2020$965,000
+7.2%
83,468
+124.9%
0.00%
Q2 2020$900,000
+212.5%
37,110
+42.1%
0.00%
Q1 2020$288,000
-65.2%
26,120
-16.6%
0.00%
Q4 2019$828,000
-53.6%
31,337
-60.0%
0.00%
Q3 2019$1,784,000
-58.9%
78,298
-44.8%
0.00%
Q2 2019$4,343,000
+1103.0%
141,740
+553.2%
0.00%
Q1 2019$361,000
-46.5%
21,700
+68.2%
0.00%
Q3 2018$675,00012,9000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders